Literature DB >> 34184067

Serum 5-Hydroxytryptamine is Related to Psoriasis Severity in Patients with Comorbid Anxiety or Depression.

Minxue Shen1, Duling Cao, Yi Xiao, Yehong Kuang, Danrong Jing, Yajia Li, Panpan Liu, Xiang Chen, Wu Zhu.   

Abstract

Entities:  

Keywords:  anxiety; depression; effect modification; serum serotonin; psoriasis

Mesh：

Substances：

Year:  2021        PMID： 34184067      PMCID： PMC9413666          DOI： 10.2340/00015555-3857

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   3.875


× No keyword cloud information.
  12 in total

1.  The expression of serotonin transporter protein correlates with the severity of psoriasis and chronic stress.

Authors:  Kristofer Thorslund; Beni Amatya; Ann Eriksson Dufva; Klas Nordlind
Journal:  Arch Dermatol Res       Date:  2012-11-17       Impact factor: 3.017

2.  Immunohistochemical Evaluation of Role of Serotonin in Pathogenesis of Psoriasis.

Authors:  Sheren Fouad Younes; Ola Ahmed Bakry
Journal:  J Clin Diagn Res       Date:  2016-10-01

3.  Psoriasis and the Risk of Depression in the US Population: National Health and Nutrition Examination Survey 2009-2012.

Authors:  Brandon E Cohen; Kathryn J Martires; Roger S Ho
Journal:  JAMA Dermatol       Date:  2016-01       Impact factor: 10.282

4.  Protective Effects of Anti-depressants against the Subsequent Development of Psoriasis in Patients with Major Depressive Disorder: a Cohort Study.

Authors:  Ya-Mei Tzeng; I-Hsun Li; Hui-Han Kao; Jui-Hu Shih; Chin-Bin Yeh; Yi-Hsien Chen; Li-Ting Kao
Journal:  J Affect Disord       Date:  2020-11-21       Impact factor: 4.839

5.  Use of serotonin reuptake inhibitors in patients with psoriasis is associated with a decreased need for systemic psoriasis treatment: a population-based cohort study.

Authors:  K Thorslund; T Svensson; K Nordlind; A Ekbom; C M Fored
Journal:  J Intern Med       Date:  2013-06-01       Impact factor: 8.989

6.  Neurotransmitter imbalance in serum of psoriatic patients in exacerbation stage with comorbid psychoemotional disorders.

Authors:  Valeriia Matiushenko; Yanina Kutasevych; Mohammad Jafferany
Journal:  Dermatol Ther       Date:  2020-04-15       Impact factor: 2.851

Review 7.  Serotonin, tryptophan metabolism and the brain-gut-microbiome axis.

Authors:  S M O'Mahony; G Clarke; Y E Borre; T G Dinan; J F Cryan
Journal:  Behav Brain Res       Date:  2014-07-29       Impact factor: 3.332

8.  Major depressive disorder increased risk of psoriasis: A propensity score matched cohort study.

Authors:  Yi-Hsien Chen; Wei-Ming Wang; I-Hsun Li; Hui-Han Kao; Chin-Bin Yeh; Li-Ting Kao
Journal:  J Affect Disord       Date:  2020-09-29       Impact factor: 4.839

9.  Reliability and validity of the Chinese version of the Patient Health Questionnaire-9 (C-PHQ-9) in patients with psoriasis: a cross-sectional study.

Authors:  Xin Ye; Hui-Ling Shu; Xia Feng; Deng-Mei Xia; Zheng-Qun Wang; Wen-Yao Mi; Bei Yu; Xue-Li Zhang; Changqiang Li
Journal:  BMJ Open       Date:  2020-07-13       Impact factor: 2.692

Review 10.  The Brain-Skin Connection and the Pathogenesis of Psoriasis: A Review with a Focus on the Serotonergic System.

Authors:  Ana M Martins; Andreia Ascenso; Helena M Ribeiro; Joana Marto
Journal:  Cells       Date:  2020-03-26       Impact factor: 6.600
View more
  3 in total

Review 1.  Role of AHR Ligands in Skin Homeostasis and Cutaneous Inflammation.

Authors:  Nieves Fernández-Gallego; Francisco Sánchez-Madrid; Danay Cibrian
Journal:  Cells       Date:  2021-11-15       Impact factor: 6.600

Review 2.  Critical Players and Therapeutic Targets in Chronic Itch.

Authors:  Hua Yang; Weiwei Chen; Renkai Zhu; Jiafu Wang; Jianghui Meng
Journal:  Int J Mol Sci       Date:  2022-09-01       Impact factor: 6.208

3.  Analysis of the Predictive Effect of Lactic Acid Combined with Cardiac Troponin T and 5-Hydroxytryptophan on the Severity of Sepsis in ICU Patients and Its Correlation with Prognosis.

Authors:  Meini Jiang; Weidong Wu; Xiuzhe Wang; Caixia Zhao
Journal:  Contrast Media Mol Imaging       Date:  2022-09-16       Impact factor: 3.009
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.